62 research outputs found
Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathway
Aims: Homozygosity for a four-missense single-nucleotide polymorphism haplotype of the human BPIFB4 gene is enriched in long-living individuals. Delivery of this longevity-associated variant (LAV) improved revascularisation and reduced endothelial dysfunction and atherosclerosis in mice through a mechanism involving the stromal cell-derived factor-1 (SDF-1). Here, we investigated if delivery of the LAV-BPIFB4 gene may attenuate the progression of diabetic cardiomyopathy. Methods and results: Compared with age-matched lean controls, diabetic db/db mice showed altered echocardiographic indices of diastolic and systolic function and histological evidence of microvascular rarefaction, lipid accumulation, and fibrosis in the myocardium. All these alterations, as well as endothelial dysfunction, were prevented by systemic LAV-BPIFB4 gene therapy using an adeno-associated viral vector serotype 9 (AAV9). In contrast, AAV9 wild-type-BPIFB4 exerted no benefit. Interestingly, LAV-BPIFB4-treated mice showed increased SDF-1 levels in peripheral blood and myocardium and up-regulation of the cardiac myosin heavy chain isoform alpha, a contractile protein that was reduced in diabetic hearts. SDF-1 up-regulation was instrumental to LAV-BPIFB4-induced benefit as both haemodynamic and structural improvements were inhibited by an orally active antagonist of the SDF-1 CXCR4 receptor. Conclusions: In mice with type-2 diabetes, LAV-BPIFB4 gene therapy promotes an advantageous remodelling of the heart, allowing it to better withstand diabetes-induced stress. These results support the viability of transferring healthy characteristics of longevity to attenuate diabetic cardiac disease
Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
Background: Loss of cardiac myocytes due to apoptosis is a relevant feature of ischemic heart disease. It has been described in infarct and peri-infarct regions of the myocardium in coronary syndromes and in ischemia-linked heart remodeling. Previous studies have provided protection against ischemia-induced cardiomyocyte apoptosis by the anti-inflammatory cytokine interleukin-1 receptor-antagonist (IL-1Ra). Mitochondria triggering of caspases plays a central role in ischemia-induced apoptosis. We examined the production of IL-1Ra in the ischemic heart and, based on dual intra/extracellular function of some other interleukins, we hypothesized that IL-1Ra may also directly inhibit mitochondria-activated caspases and cardiomyocyte apoptosis.
Methodology/Principal Findings: Synthesis of IL-1Ra was evidenced in the hearts explanted from patients with ischemic heart disease. In the mouse ischemic heart and in a mouse cardiomyocyte cell line exposed to long-lasting hypoxia, IL-1Ra bound and inhibited mitochondria-activated caspases, whereas inhibition of caspase activation was not observed in the heart of mice lacking IL-1Ra (Il-1ra−/−) or in siRNA to IL-1Ra-interfered cells. An impressive 6-fold increase of hypoxia-induced apoptosis was observed in cells lacking IL-1Ra. IL-1Ra down-regulated cells were not protected against caspase activation and apoptosis by knocking down of the IL-1 receptor, confirming the intracellular, receptor-independent, anti-apoptotic function of IL-1Ra. Notably, the inhibitory effect of IL-1Ra was not influenced by enduring ischemic conditions in which previously described physiologic inhibitors of apoptosis are neutralized.
Conclusions/Significance: These observations point to intracellular IL-1Ra as a critical mechanism of the cell self-protection against ischemia-induced apoptosis and suggest that this cytokine plays an important role in the remodeling of heart by promoting survival of cardiomyocytes in the ischemic regions
Avaliação psicométrica do Questionário de Mudança Corporal para adolescentes
Resumo O estudo objetivou analisar a validade de construto, consistência interna e reprodutibilidade do Questionário de Mudança Corporal (QMC). Foram avaliados 439 meninas e meninos (13 a 22 anos). A validade de construto foi avaliada por meio da análise fatorial exploratória e correlações entre os escores do QMC, Body Shape Questionnaire (BSQ) e Escala de Silhuetas (ES). A confiabilidade foi acessada usando-se a consistência interna, e a reprodutibilidade pelo teste-reteste e pela correlação intraclasse. A escala apresentou estrutura fatorial composta por seis fatores, os quais representaram quase em sua totalidade as subescalas do instrumento. As correlações para a amostra total entre o QMC e as outras escalas variaram de 0,37 a 0,46. A consistência interna apresentou valores entre 0,78 e 0,96 para cada um dos fatores, e a correlação intraclasse foi condizente com uma boa reprodutibilidade. Os escores do teste-reteste não apresentaram diferenças significantes para a amostra total e entre os sexos. Conclui-se que o QMC apresenta boas qualidades psicométricas para os adolescentes brasileiros
Biodiversità araneologica (Araneae) in meleti sottoposti a differenti input fitosanitari
Extended laboratory methods to determine effects of plant protection products on two strains of Amblyseius andersoni Chant and their resistance level
RIGHT-VENTRICULAR DYSPLASIA - RIGHT AND LEFT-VENTRICULAR INVOLVEMENT MORPHOMETRICALLY EVALUATED
Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene
- …